Welcome to our dedicated page for Babcock & Wilcox Enterprises I SEC filings (Ticker: BW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Babcock & Wilcox Enterprises, Inc. filings document the formal disclosures of an energy technology and environmental products company serving power and industrial markets. Recent 8-K reports cover operating results, Regulation FD investor materials, material definitive agreements for natural gas-fired boiler and steam turbine systems, amendments to credit and security agreements, and dividends on the 7.75% Series A Cumulative Perpetual Preferred Stock.
Proxy and governance filings describe annual meeting proposals, board composition, director compensation policies, officer transitions, indemnification agreements, and stockholder voting matters. The filing record also identifies the company’s public securities, including common stock, preferred stock and 6.50% senior notes due 2026, alongside forward-looking disclosure tied to its project pipeline and technology portfolio.
Babcock & Wilcox Enterprises, Inc. reported results of its May 20, 2026 annual meeting and an increase to its long-term incentive equity pool. Stockholders approved an amendment to the 2021 Long-Term Incentive Plan, raising the shares authorized for awards from 5,250,000 to 10,250,000.
Proposals to declassify the Board and to remove 80% supermajority voting requirements received majority support but did not meet the 80% voting-power threshold, so they were not approved. Stockholders elected two Class II directors, ratified BDO USA, P.C. as auditor for 2026, approved executive compensation on an advisory basis, and approved the incentive plan amendment.
Babcock & Wilcox Enterprises, Inc. registers 11,657,221 shares of Common Stock for resale by selling stockholders, including 1,197,221 issued shares and up to 10,460,000 shares issuable upon exercise of warrants, from time to time after this registration statement becomes effective. The company states it is not selling any shares under this prospectus and will receive no proceeds from the selling stockholders’ resales. The prospectus ties the resale registration to warrants issued in connection with prior private placements and commercial arrangements and identifies 148,839,531 shares outstanding as of May 19, 2026.
Babcock & Wilcox Enterprises, Inc. registers 11,657,221 shares of Common Stock for resale by selling stockholders. The registration covers 1,197,221 currently outstanding shares and up to 10,460,000 shares issuable upon exercise of warrants, and the company will not receive proceeds from these resales.
The prospectus discloses 148,839,531 shares outstanding as of May 19, 2026, an NYSE listing under "BW", and a May 20, 2026 closing price of $19.17 per share. Sales may occur from time to time through brokerage or other permitted means under the plan of distribution.
Babcock & Wilcox Enterprises director Naomi Louise Boness reported compensation-related equity activity involving restricted stock units and common stock. On May 15, 2026, she exercised or converted derivative securities into 85,000 shares of common stock and received a new grant of 8,725 restricted stock units under the company’s Amended and Restated 2021 Long-Term Incentive Plan.
A portion of the vested restricted stock units representing 46,750 shares was settled in cash by the company to facilitate her tax payments, classified as a disposition to the issuer. Following these transactions, she directly owned 189,530 shares of common stock. The new restricted stock units are scheduled to vest on May 15, 2026 and May 15, 2027, or on the date of the next annual meeting in each case, whichever is earlier.
Babcock & Wilcox Enterprises, Inc. director Rebecca L. Stahl reported compensation-related equity moves. She exercised 85,000 restricted stock units into common stock and the company settled 46,750 common shares with her at $21.22 per share to facilitate tax payments. After these transactions she directly holds 184,013 common shares and 8,725 restricted stock units, with the new units vesting on May 15, 2027 or the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises director Alan B. Howe reported several equity compensation-related transactions in company stock. On May 15, 2026, he exercised 85,000 Restricted Stock Units, which converted into an equal number of common shares at a stated value of $21.22 per share. The filing notes that a portion of the vested restricted stock units was settled in cash by Babcock & Wilcox to facilitate his tax payments, rather than through open-market sales.
Following these transactions, Howe held 165,994 shares of common stock directly, in addition to indirect holdings of 72,606 shares through the Alan & Penny Howe Trust, where he serves as trustee, and 13,000 shares in an IRA. He also received a new grant of 8,725 Restricted Stock Units under the company’s Amended and Restated 2021 Long-Term Incentive Plan, representing a contingent right to receive common stock, with vesting tied to future dates or the next annual meeting.
Babcock & Wilcox Enterprises director Dr. Homaira Akbari reported equity-based compensation activity. On May 15, 2026, she exercised 3,021 shares of common stock at $21.22 per share from restricted stock units and held 53,021 common shares afterward.
She also received 8,725 new restricted stock units tied to common stock, which vest on May 15, 2027 or the next annual meeting, and previously received 3,021 restricted stock units that vest on May 15, 2026. After these grants, she directly holds both common shares and unvested restricted stock units.
Babcock & Wilcox Enterprises director Philip D. Moeller reported compensation-related share activity involving restricted stock units. He exercised or converted 85,000 restricted stock units into common stock, and 46,750 shares were settled in cash by the company to cover tax payments under the award terms. After these transactions, he directly held 235,809 shares of common stock. Moeller also received a new grant of 8,725 restricted stock units under the Amended and Restated 2021 Long-Term Incentive Plan, which are scheduled to vest on May 15, 2027 or on the date of the next annual meeting, whichever is earlier.
Babcock & Wilcox Enterprises director Joseph A. Tato reported compensation-related equity activity. On May 15, 2026, he exercised 85,000 restricted stock units into common stock at a reported value of $21.22 per share. To facilitate tax payments, 46,750 shares were settled back to the company in cash under the award terms, rather than sold on the open market. Following these transactions, he directly held 254,088 common shares. He also received a new grant of 8,725 restricted stock units under the Amended and Restated 2021 Long-Term Incentive Plan, each representing one share of common stock, vesting by May 15, 2027 or the next annual meeting, whichever is earlier.